Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 27Neoplasms 3Neoplasm Metastasis 3Metastatic Castration-Resistant Prostate Cancer 3Prostatic Neoplasms, Castration-Resistant 2Metastatic Hormone-sensitive Prostate Cancer 2Bulbo-Spinal Atrophy, X-Linked 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1Metastatic Castration-resistant Prostate Neoplasms 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, Follicular 1Colorectal Neoplasms 1Castrate Sensitive Prostate Cancer 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Bites and Stings 1Advanced Prostate Cancer 1Adenocarcinoma 1

Interventions

Nivolumab 22Specimen Handling 17pembrolizumab 13cabozantinib 13Magnetic Resonance Spectroscopy 13belzutifan 12Ipilimumab 12lenvatinib 7Axitinib 7CTLA-4 Antigen 6Biopsy 6atezolizumab 4Sunitinib 4tivozanib 3Surveys and Questionnaires 3Immunoglobulin G 3Everolimus 3Disulfides 3relatlimab 2pazopanib 2palbociclib 2aldesleukin 2Watchful Waiting 2Standard of Care 2Radiosurgery 2Practice Guidelines as Topic 2Nephrectomy 2Bevacizumab 2zimberelimab 1ulixertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × enzalutamide × 30 days × Clear all
NCT07620574 2026-06-02

Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

Exelixis

Phase 3 Not yet recruiting
5,000 enrolled
GastrointestinalGenitourinary

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡